Other languages Zomedica Corp.

Equities

ZOM

CA98980M1095

Market Closed - Nyse Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
0.145 ^USD	-0.21%		-0.82%	-27.57%

Jun. 27	Zomedica Launches Equine Cortisol Measurement Test on Truforma Platform	MT
Jun. 27	Zomedica Corp. Expands Truforma Addressable Market with Launch of Equine Cortisol Assay for the Platform	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Zomedica Launches Equine Cortisol Measurement Test on Truforma Platform	Jun. 27
Zomedica Corp. Expands Truforma Addressable Market with Launch of Equine Cortisol Assay for the Platform	Jun. 27
Zomedica Pharmaceuticals Gets CE Mark for Truforma Platform to Expand in Europe	Jun. 25
Zomedica Completes Expansion of Manufacturing, Distribution Facilities in Roswell, Georgia	Jun. 04
Zomedica Corp. Releases Over-The-Air Software Update Capabilities for Its Truforma(R) Platform	May. 15
Zomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Zomedica Corp. Provides Revenue Guidance for Full Year 2024	May. 09
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01
Zomedica Seeks Acquisitions	Apr. 01
Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024	Apr. 01
Zomedica Corp. Announces Publication of Research Con Including TRUFORMA(R) Platform Is More Accurate Diagnostic Test for Feline Hyperthyroidism Than Chemiluminescent Immunoassay Platform	Mar. 14
Zomedica Pharmaceuticals Reports Preliminary Q4 Revenue	Jan. 17
Zomedica Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Full Year 2024	Jan. 17
Zomedica Corp. Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease	Dec. 18
Zomedica Announces Presentation of Clinical Data in Support of New Indications for Pulsevet Shock Wave Therapy	Dec. 06
Zomedica Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Zomedica Corp. acquired Qorvo Biotechnologies, LLC from Qorvo US, Inc. for $11.3 million.	23-10-04
Zomedica Corp. Launches its Newest Assay - Endogenous ACTH	23-09-14
Zomedica Pharmaceuticals Issued Warning From NYSE American For Failing to Meet Listing Requirement	23-09-13
Zomedica Completes Acquisition of Structured Monitoring Products	23-09-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zomedica Corp.

Equities

ZOM

CA98980M1095

Other languages

Filters